GSA Capital Partners’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
NAMI
B
GSA Capital Partners's NEO Position: Q2 2026 in Review
GSA Capital Partners sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 54,385 shares — an estimated $404K sold.
GSA Capital Partners first reported a position in NEO in Q2 2013 and held it in 11 quarters. The position peaked at $697K in Q4 2018. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- GSA Capital Partners reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
- GSA Capital Partners sold 54,385 NeoGenomics shares in Q2 2026, an estimated $404K.
- GSA Capital Partners first reported a position in NeoGenomics in Q2 2013 and held it in 11 quarters.
- GSA Capital Partners's NeoGenomics position peaked at $697K in Q4 2018.
- 267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.